A First-in-human Trial of SZN-8141 in Diabetic Macular Edema

by | Sep 14, 2026 | Clinical Trials | 0 comments

​ Conditions: Diabetic Macular Edema (DME)

Interventions: Biological: SZN-8141 for Injection

Sponsors: Surrozen Operating, Inc.

Not yet recruiting Conditions: Diabetic Macular Edema (DME)
Interventions: Biological: SZN-8141 for Injection
Sponsors: Surrozen Operating, Inc.
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *